Burgeoning Demand for Neuraminidase Inhibitors Market to Fuel Growth Through 2019 - 2029

25/mar/2020 06:13:49 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Influenza viruses are characterized by two surface glycoproteins ie hemagglutinnin and neuraminidase. Neuraminidase are the antigens which play an important role in defining the particular strain of influenza. Dosage and safety of neuraminidase inhibitors are the two main parameters, affecting the growth of neuraminidase inhibitors market.

The various symptoms of influenza are cough, running nose, fever, headache, fatigue, chills etc. The neuraminidase are recommended for the treatment of the symptoms after the forty eight hours of start of these symptoms.

There are few neuraminidase inhibitors, being sold in the market. The neuraminidase inhibitors have been classified as zenamivir, oseltamivir, peramivir, leninamivir and few other neuraminidase inhibitors. Zenamivir and oseltamivir are the neuraminidase inhibitors which are being used for the treatment of influenza A or influenza B.

To Remain ‘Ahead’ Of Your Competitors, Request for a Sample Here @ https://www.persistencemarketresearch.com/samples/31232  

One of the main advantages of neuraminidase inhibitors is the rare development of resistance. The resistance against neuraminidase inhibitors occurs very rarely, which is expected to increase the usage of neuraminidase inhibitors for the treatment of influenza.

The manufacturing companies in the neuraminidase inhibitors market are focusing on the development of new drugs in the market, which is expected to grow the neuraminidase inhibitors market in the forecast years.

Increasing prevalence of influenza is one of the major factor, responsible for the growth of neuraminidase inhibitors market. Increasing awareness among the people, is also expected to increase the growth of the neuraminidase inhibitors market.

Other factors such as increasing number of hospital and diagnostic laboratories, development of healthcare infrastructure especially in developing regions, increasing population etc., are expected to hold a large revenue share in the neuraminidase inhibitors market.

Favourable reimbursement policies are also expected to hold a large revenue share in the neuraminidase inhibitors market. Increasing research and development expenditure and technological advancement, is expected to increase the overall growth of neuraminidase inhibitors market.

Apart from the factors, driving the growth of neuraminidase inhibitors market, there are a few factors which are expected to hinder the growth of neuraminidase inhibitors market.

Adverse drug reactions, such as vomiting, nausea, abdominal pain etc., are expected to decrease the demand of neuraminidase inhibitors market, hence can hinder the growth of the overall neuraminidase inhibitors market. Lack of awareness, in some emerging regions, can be a key factor which can hinder the overall growth of neuraminidase inhibitors market.

Access Full TOC of This Report @ https://www.persistencemarketresearch.com/toc/31232     

The global Neuraminidase inhibitors market is segmented on the basis of Application, End User and geography:

  • Segmentation by Drug Type
    • Zanamivir
    • Oseltamivir
    • Peramivir
    • Laninamivir
  • Segmentation by Route of Administration
    • Oral
    • Nasal
    • Parenteral
  • Segmentation by Distribution Channel
    • Hospital Pharmacies
    • Drug Stores
    • Retail Stores
    • Others

Based on the drug type, the neuraminidase inhibitors market has been segmented into zanamivir, oseltamivir, peramivir and laninamivir. Zanamivir is expected to hold a large revenue share in the neuraminidase inhibitors market.

Based on the route of administration, the neuraminidase inhibitors market has been segmented into oral route of administration, nasal route of administration and the parenteral route of administration. Oral route of administration is generally preferred for the intake of treatment drugs.

Based on the distribution channel, the neuraminidase inhibitors market has been segmented into hospital pharmacies, drug stores, retail stores and others. Hospital pharmacies, is expected to hold a large revenue share in the neuraminidase inhibitors market.

Geographically, global neuraminidase inhibitors market has been segmented into several key regions i.e.  North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa. North America is expected to dominate the global neuraminidase inhibitors market, owing to a well-developed healthcare infrastructure.

Europe is also expected to hold a large revenue share in the neuraminidase inhibitors market due to increasing research and developmental activities. Asia Pacific is expected to show a significant growth in the neuraminidase inhibitors market, because of the large population and increasing prevalence of influenza, among the people.

There are few companies in the neuraminidase inhibitors market. GlaxoSmithKline, Gilead Sciences, F. Hoffman-La Roche, BioCryst Ltd. and Daiichi Sankyo Co. Ltd. are some of the key players, in the neuraminidase inhibitors market.

For In-Depth Competitive Analysis, Buy Now @ https://www.persistencemarketresearch.com/checkout/31232

The report covers exhaustive analysis on:

  • Neuraminidase inhibitors Market Segments
  • Neuraminidase inhibitors Market Dynamics
  • Historical Actual Market Size, 2013 – 2015
  • Neuraminidase inhibitors Market Size & Forecast 2016 to 2024
  • Neuraminidase inhibitor Agents Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Neuraminidase inhibitors Market Drivers and Restraints

Regional analysis includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth Neuraminidase inhibitor market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies for key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance
 

More About the Report –

Unprecedented access to a world of information has given rise to the empowered, albeit distrustful, consumer. So is the case with healthcare, where the patient has been rendered more informed and conscientious thanks to the extraordinary penetration of the Internet. The discerning patient now demands more affordable, sophisticated, transparent, and personalized healthcare services, creating the need for new models for care.

The advent of health information technology (HIT) components such as electronic health records (EHR), hospital information systems (HIS), picture archiving and communication systems (PACS), and vendor-neutral archives (VNA) has had just as transformational an impact on the overall healthcare sector as the concerns regarding security and privacy. Data theft, undue access to personal health records, and cyber-attacks are very real threats that the healthcare sector faces today.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Animal Healthcare Market –

According to a report published by Persistence Market Research (PMR), the global animal healthcare market is expected to witness a CAGR of 4.8% from 2017 to 2025. In 2017, the market was worth US$ 30,744.2 Mn and is estimated to rise to a valuation of US$ 44,847.2 Mn by the end of 2025.

Dental Implants Market –

According to a new market report published by Persistence Market Research “Global Market Study on Dental Implants – Asia Pacific to Witness Fastest Growth by 2020,” the global Dental implants market was valued at USD 4,508.9 million in 2014 and is expected to grow at a CAGR of 9.7% from 2014 to 2020, to reach an estimated value of USD 7,879.5 million in 2020.

Globally, rising aging population has increases the demand for dental implants in the market. As a result, the market is expected to grow at a CAGR of about 9.7% from 2014 – 2020.

Bioinformatics Market –

According to a new market report published by Persistence Market Research “Global Market Study on Bioinformatics – Asia to Witness Fastest Growth by 2020,” the global bioinformatics market was valued at USD 4,110.6 million in 2014 and is expected to grow at a CAGR of 20.4% from 2014 to 2020, to reach an estimated value of USD 12,542.4 million in 2020.

Globally, rising R&D expenditures and a rising number of research activities have increased the demand for bioinformatics in the market. As a result, the market is expected to grow at a CAGR of about 20.4% from 2014 – 2020.

Hospital Beds Market – 

According to a new market report published by Persistence Market Research “Global Market Study on Hospital Beds: Asia to Witness Highest Growth by 2020”, the global hospital beds market was valued at USD 5,254.2 million in 2014 and is expected to expand at a CAGR of 4.2% from 2014 to 2020, to reach an estimated value of USD 6,731.8 million by 2020.

Cleanroom Technology Market –

According to a new market report published by Persistence Market Research titled Global Market Study on  Cleanroom Technology : Consumables to Witness Highest Growth by 2020, the global  cleanroom technology market  was valued at USD 3,156.0 million in 2014 and is expected to grow at a CAGR of 5.2 % from 2014 to 2020 to reach an estimated value of USD 4,290.1 ​​million by 2020.

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR's collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

305 Broadway, 7th Floor
New York City, NY 10007
United States
Ph.no. + 1-646-568-7751
E-mail id-  sales@persistencemarketresearch.com
Website:  https://www.persistencemarketresearch.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl